Acido tiludronico [INN-Spanish]
Brand names,
Acido tiludronico [INN-Spanish]
Analogs
Acido tiludronico [INN-Spanish]
Brand Names Mixture
Acido tiludronico [INN-Spanish]
Chemical_Formula
C15H15NO3
Acido tiludronico [INN-Spanish]
RX_link
http://www.rxlist.com/cgi/generic2/tolmetin.htm
Acido tiludronico [INN-Spanish]
fda sheet
Acido tiludronico [INN-Spanish]
msds (material safety sheet)
Acido tiludronico [INN-Spanish]
Synthesis Reference
No information avaliable
Acido tiludronico [INN-Spanish]
Molecular Weight
257.285 g/mol
Acido tiludronico [INN-Spanish]
Melting Point
156 oC
Acido tiludronico [INN-Spanish]
H2O Solubility
222 mg/L
Acido tiludronico [INN-Spanish]
State
Solid
Acido tiludronico [INN-Spanish]
LogP
2.469
Acido tiludronico [INN-Spanish]
Dosage Forms
Tablet (oral, equivalent to 200 mg or 600 mg of tolmetin); Capsule (oral, equivalent to 400 mg of tolmetin)
Acido tiludronico [INN-Spanish]
Indication
For the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, including the treatment of acute flares long-term management. Also for treatment of juvenile rheumatoid arthritis.
Acido tiludronico [INN-Spanish]
Pharmacology
Tolmetin is a nonsteroidal anti-inflammatory agent. Studies in animals have shown tolmetin to possess anti-inflammatory, analgesic and antipyretic activity. In the rat, tolmetin prevents the development of experimentally induced polyarthritis and also decreases established inflammation. In patients with either rheumatoid arthritis or osteaoarthritis, tolmetin is as effective as aspirin and indomethacin in controlling disease activity, but the frequency of the milder gastrointestinal adverse effects and tinnitus was less than in aspirin-treated patients, and the incidence of central nervous system adverse effects was less than in indomethacin-treated patients. In patients with juvenile rheumatoid arthritis, tolmetin is as effective as aspirin in controlling disease activity, with a similar incidence of adverse reactions. tolmetin has produced additional therapeutic benefit when added to a regimen of gold salts and, to a lesser extent, with corticosteroids. Tolmetin should not be used in conjunction with salicylates since greater benefit from the combination is not likely, but the potential for adverse reactions is increased.
Acido tiludronico [INN-Spanish]
Absorption
Rapidly and almost completely absorbed with peak plasma levels being reached within 30-60 minutes after an oral therapeutic dose.
Acido tiludronico [INN-Spanish]
side effects and Toxicity
Symptoms of overdose include lethargy, drowsiness, nausea, vomiting, and epigastric pain.
Acido tiludronico [INN-Spanish]
Patient Information
Acido tiludronico [INN-Spanish]
Organisms Affected
Humans and other mammals